Press Releases

Date	Title and Summary	View
Oct 12, 2021	PerkinElmer Schedules Earnings Call for Tuesday, November 2, 2021
Oct 7, 2021	PerkinElmer Receives FDA Emergency Use Authorization for Respiratory SARS-CoV-2 Panel
Oct 6, 2021	PerkinElmer’s Horizon Discovery CHOSOURCE™ Platform Expanding To Include CHO-K1 ADCC+ Expression Cell Line for Development of Therapeutic Antibodies in Oncology, Infectious Disease and Autoimmune Conditions
Oct 5, 2021	EUROIMMUN Anti-SARS-CoV-2 S1 Curve ELISA Receives FDA Emergency Use Authorization
Sep 29, 2021	UPM Biomedicals and PerkinElmer collaborate to offer high throughput 3D cell screening solution
Sep 17, 2021	PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend
Sep 8, 2021	PerkinElmer Prices Offering of Senior Notes
Aug 24, 2021	PerkinElmer to Present at 2021 Baird Global Healthcare Conference
Aug 19, 2021	PerkinElmer Expands Automated Mycotoxin Detection Kits Portfolio to Include All Major Mycotoxins
Jul 28, 2021	PerkinElmer Expands KRAS Oncology Drug Discovery Assays with New Ready-to-Use AlphaLISA Kits